Abstract
The plants of Salacia genus (Celastraceae) have distribution in tropical areas, especially in regions of Asia as in India, Sri Lanka, Thailand and Indonesia, and in South America, as in Brazil. Around the world, about 120 species are known. Salacia`s species are known to elaborate secondary metabolites like anthocyanidines, catechins, phenolic acids, quinones, friedo-oleanones, quinonemethide and related triterpenoids (celastroloids). Biological activities have been reported for crude extracts, fractions and isolated compounds, which are mainly antidiabetic, antioxidant and anti-inflammatory. This review aims to identify key species, their chemical components, and the reported bioactivity as a guide to future research about this genus.
Keywords: Biological actions, diabetes, phytochemistry, Salacia genus.
The Natural Products Journal
Title:Genus Salacia: Chemical Composition, Antidiabetic Effect and other Bioactivities
Volume: 5 Issue: 4
Author(s): Manuela M. Laikowski, Debora M. de Souza and Sidnei Moura
Affiliation:
Keywords: Biological actions, diabetes, phytochemistry, Salacia genus.
Abstract: The plants of Salacia genus (Celastraceae) have distribution in tropical areas, especially in regions of Asia as in India, Sri Lanka, Thailand and Indonesia, and in South America, as in Brazil. Around the world, about 120 species are known. Salacia`s species are known to elaborate secondary metabolites like anthocyanidines, catechins, phenolic acids, quinones, friedo-oleanones, quinonemethide and related triterpenoids (celastroloids). Biological activities have been reported for crude extracts, fractions and isolated compounds, which are mainly antidiabetic, antioxidant and anti-inflammatory. This review aims to identify key species, their chemical components, and the reported bioactivity as a guide to future research about this genus.
Export Options
About this article
Cite this article as:
M. Laikowski Manuela, M. de Souza Debora and Moura Sidnei, Genus Salacia: Chemical Composition, Antidiabetic Effect and other Bioactivities, The Natural Products Journal 2015; 5 (4) . https://dx.doi.org/10.2174/2210315505666150930225628
DOI https://dx.doi.org/10.2174/2210315505666150930225628 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Decreasing Arterial Aging by Controlling Blood Pressure Levels and Hypertension: A Step Forward
Current Vascular Pharmacology Tackling the Elusive Challenges Relevant to Conquering the 100-Plus Year Old Problem of Alzheimer’s Disease
Current Alzheimer Research S100A1: Structure, Function, and Therapeutic Potential
Current Chemical Biology Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians
Endocrine, Metabolic & Immune Disorders - Drug Targets The Therapeutic Implications of Renin-Angiotensin System Blockade in Diabetic Retinopathy
Current Pharmaceutical Biotechnology The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia
Current Topics in Medicinal Chemistry Gait-Related Strategies for the Prevention of Plantar Ulcer Development in the High Risk Foot
Current Diabetes Reviews Contrast Medium Induced Nephropathy: New Insights into Prevention and Risk Management
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Biological Therapies for Inflammatory Bowel Disease
Current Pharmaceutical Design Cancer Stem Cells and their Management in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Inhibitors of 11β-HSD1: A Potential Treatment for the Metabolic Syndrome
Current Topics in Medicinal Chemistry Angiotensin-TGF-β1 Crosstalk in Human Idiopathic Pulmonary Fibrosis:Autocrine Mechanisms in Myofibroblasts and Macrophages
Current Pharmaceutical Design Indolo[3,2-b]quinolines: Synthesis, Biological Evaluation and Structure Activity-Relationships
Mini-Reviews in Medicinal Chemistry Current Metabolomic Methodologies & their Application to Thermal Stress
Current Metabolomics Novel Insights into Vascular Repair Mechanisms
Current Pharmaceutical Design Contribution of ALDH2 Polymorphism to Alcoholism-Associated Hypertension
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Prevalence of the Classical and Non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients
CNS & Neurological Disorders - Drug Targets Metformin: Is it Still the First Line in Type 2 Diabetes Management Algorithm?
Current Pharmaceutical Design Possible Roles of Reg Family Proteins in Pancreatic Islet Cell Growth
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Combined Assessment of Defense Against Oxidative Stress and Inflammation in the Evaluation of Peripheral Arterial Disease
Current Molecular Medicine